Do you avoid high-potency P2Y12 inhibitors in favor of clopidogrel in patients with atrial fibrillation on a DOAC who undergo PCI?
Tannu M, et al, PMID 39918467
Community PollStarted
Do you avoid high-potency P2Y12 inhibitors in favor of clopidogrel in patients with atrial fibrillation on a DOAC who undergo PCI?
45 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet Member
Cardiology · Iowa Heart Center West Des Moines
Answered on
Not in all cases, favor high potency P2Y12 in high-risk coronary/complex anatomy, clopidogrel in high-risk bleeding patients.
Join for free or sign in to see the full answer